CDMO of CytoNiche Facilitates Commercialization of Cell Therapy Products | Stem Cell Therapy Products and Services
2022-08-31
News
Focusing on innovative 3D cell technology products and services
2018
- Categories:Enterprise Development
- Author:
- Origin:
- Time of issue:2018-09-16
- Views:0
(Summary description)In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.
2018
(Summary description)In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.
- Categories:Enterprise Development
- Author:
- Origin:
- Time of issue:2018-09-16
- Views:0
Information
In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.
Scan the QR code to read on your phone
Previous:
March 2019
Previous:
March 2019
Previous :
March 2019
Previous :
March 2019
Latest News
-
Phone
- Service hotline+86 15984333494
-
E-mail
- E-mailgulx@cytoniche.com
- TOP
京公网安备 11010802037749号